Search Results

You are looking at 51 - 60 of 126 items for :

  • "glycemic control" x
Clear All
Paraskevi Kazakou Diabetes Centre, Department of Clinical Therapeutics, Alexandra Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece

Search for other papers by Paraskevi Kazakou in
Google Scholar
PubMed
Close
,
Stavroula A Paschou Endocrine Unit, Department of Clinical Therapeutics, Alexandra Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece

Search for other papers by Stavroula A Paschou in
Google Scholar
PubMed
Close
,
Theodora Psaltopoulou Unit of Hematology and Oncology, Department of Clinical Therapeutics, Alexandra Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece

Search for other papers by Theodora Psaltopoulou in
Google Scholar
PubMed
Close
,
Maria Gavriatopoulou Unit of Hematology and Oncology, Department of Clinical Therapeutics, Alexandra Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece

Search for other papers by Maria Gavriatopoulou in
Google Scholar
PubMed
Close
,
Eleni Korompoki Department of Clinical Therapeutics, Alexandra Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece

Search for other papers by Eleni Korompoki in
Google Scholar
PubMed
Close
,
Katerina Stefanaki Endocrine Unit, Department of Clinical Therapeutics, Alexandra Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece

Search for other papers by Katerina Stefanaki in
Google Scholar
PubMed
Close
,
Fotini Kanouta Department of Endocrinology, Alexandra Hospital, Athens, Greece

Search for other papers by Fotini Kanouta in
Google Scholar
PubMed
Close
,
Georgia N Kassi Department of Endocrinology, Alexandra Hospital, Athens, Greece

Search for other papers by Georgia N Kassi in
Google Scholar
PubMed
Close
,
Meletios-Athanasios Dimopoulos Unit of Hematology and Oncology, Department of Clinical Therapeutics, Alexandra Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece

Search for other papers by Meletios-Athanasios Dimopoulos in
Google Scholar
PubMed
Close
, and
Asimina Mitrakou Diabetes Centre, Department of Clinical Therapeutics, Alexandra Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece

Search for other papers by Asimina Mitrakou in
Google Scholar
PubMed
Close

Glucose metabolism Hyperglycemia on admission/during hospitalization (22, 23, 24, 25) New presentation of DM with DKA or hyperosmolarity (38, 39, 40, 41, 42) Insulin-dependent DM or precipitation of T1DM (47, 48) Aggravation of glycemic control in

Open access
Mônica R Gadelha Endocrine Unit, Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil

Search for other papers by Mônica R Gadelha in
Google Scholar
PubMed
Close
,
Feng Gu Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital, Beijing, China

Search for other papers by Feng Gu in
Google Scholar
PubMed
Close
,
Marcello D Bronstein Neuroendocrine Unit, Division of Endocrinology and Metabolism, University of São Paulo Medical School, São Paulo, Brazil

Search for other papers by Marcello D Bronstein in
Google Scholar
PubMed
Close
,
Thierry C Brue Aix-Marseille Université, Institut National de la Santé et de la Recherche Médicale, Marseille Medical Genetics, and Assistance Publique Hôpitaux de Marseille, Department of Endocrinology, Hôpital de la Conception, Centre de Référence des Maladies Rares de l’Hypophyse, Marseille, France

Search for other papers by Thierry C Brue in
Google Scholar
PubMed
Close
,
Maria Fleseriu Northwest Pituitary Center, Oregon Health & Science University, Portland, Oregon, USA

Search for other papers by Maria Fleseriu in
Google Scholar
PubMed
Close
,
Ilan Shimon Institute of Endocrinology and Metabolism, Rabin Medical Center, and Sackler School of Medicine, Tel-Aviv University, Petah-Tiqva, Israel

Search for other papers by Ilan Shimon in
Google Scholar
PubMed
Close
,
Aart J van der Lely Erasmus University Medical Center, Rotterdam, The Netherlands

Search for other papers by Aart J van der Lely in
Google Scholar
PubMed
Close
,
Shoba Ravichandran Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA

Search for other papers by Shoba Ravichandran in
Google Scholar
PubMed
Close
,
Albert Kandra Recordati AG, Basel, Switzerland

Search for other papers by Albert Kandra in
Google Scholar
PubMed
Close
,
Alberto M Pedroncelli Recordati AG, Basel, Switzerland

Search for other papers by Alberto M Pedroncelli in
Google Scholar
PubMed
Close
, and
Annamaria A L Colao Dipartimento di Medicina Clinica e Chirurgia, Sezione di Endocrinologia, Università Federico II di Napoli, Naples, Italy

Search for other papers by Annamaria A L Colao in
Google Scholar
PubMed
Close

. Glycemic control The HbA 1c values of individual patients were evaluated at month 12 (C2305) and month 6 (C2402), or at the last available time point for patients who discontinued treatment early. At the end of the core phases of both studies, 78.1% of C

Open access
Rama Lakshman Wellcome-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, UK

Search for other papers by Rama Lakshman in
Google Scholar
PubMed
Close
,
Charlotte Boughton Wellcome-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, UK
Cambridge University Hospitals NHS Foundation Trust, Wolfson Diabetes and Endocrine Clinic, Cambridge, UK

Search for other papers by Charlotte Boughton in
Google Scholar
PubMed
Close
, and
Roman Hovorka Wellcome-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, UK

Search for other papers by Roman Hovorka in
Google Scholar
PubMed
Close

) 9 Beck RW Riddlesworth T Ruedy K Ahmann A Bergenstal R Haller S Kollman C Kruger D McGill JB Polonsky W , Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the

Open access
Aliyu Tijani Jibril Department of Community Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran

Search for other papers by Aliyu Tijani Jibril in
Google Scholar
PubMed
Close
,
Ahmad Jayedi Social Determinants of Health Research Center, Semnan University of Medical Sciences, Semnan, Iran

Search for other papers by Ahmad Jayedi in
Google Scholar
PubMed
Close
, and
Sakineh Shab-Bidar Department of Community Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran

Search for other papers by Sakineh Shab-Bidar in
Google Scholar
PubMed
Close

with type 2 diabetes. The intervention duration ranged from 4 weeks ( 47 ) to 52 weeks ( 35 ). The median sample size was 65 participants (range 14–135). In all, 11 studies reported on baseline glycemic control of patients ( 35 , 36 , 37 , 39 , 42

Open access
Tingting Jia Department of Implantology, School of Stomatology, Shandong University, Jinan, People’s Republic of China
Shandong Provincial Key Laboratory of Oral Tissue Regeneration, Jinan, People’s Republic of China

Search for other papers by Tingting Jia in
Google Scholar
PubMed
Close
,
Ya-nan Wang Department of Implantology, School of Stomatology, Shandong University, Jinan, People’s Republic of China
Shandong Provincial Key Laboratory of Oral Tissue Regeneration, Jinan, People’s Republic of China

Search for other papers by Ya-nan Wang in
Google Scholar
PubMed
Close
,
Dongjiao Zhang Department of Implantology, School of Stomatology, Shandong University, Jinan, People’s Republic of China
Shandong Provincial Key Laboratory of Oral Tissue Regeneration, Jinan, People’s Republic of China

Search for other papers by Dongjiao Zhang in
Google Scholar
PubMed
Close
, and
Xin Xu Department of Implantology, School of Stomatology, Shandong University, Jinan, People’s Republic of China
Shandong Provincial Key Laboratory of Oral Tissue Regeneration, Jinan, People’s Republic of China

Search for other papers by Xin Xu in
Google Scholar
PubMed
Close

,25VD 3 mediates osseointegration is unclear, particularly under conditions of poor glycemic control. Therefore, we assume that the potential lessening of 1,25VD 3 and accumulating of AGEs in T2DM patients may lead to implantation failure. The

Open access
A H Ludwig-Slomczynska Center for Medical Genomics OMICRON, Jagiellonian University Medical College, Krakow, Poland

Search for other papers by A H Ludwig-Slomczynska in
Google Scholar
PubMed
Close
,
S Borys Department of Metabolic Diseases, Jagiellonian University Medical College
University Hospital, Krakow, Poland

Search for other papers by S Borys in
Google Scholar
PubMed
Close
,
M T Seweryn Center for Medical Genomics OMICRON, Jagiellonian University Medical College, Krakow, Poland

Search for other papers by M T Seweryn in
Google Scholar
PubMed
Close
,
J Hohendorff Department of Metabolic Diseases, Jagiellonian University Medical College
University Hospital, Krakow, Poland

Search for other papers by J Hohendorff in
Google Scholar
PubMed
Close
,
P Kapusta Center for Medical Genomics OMICRON, Jagiellonian University Medical College, Krakow, Poland

Search for other papers by P Kapusta in
Google Scholar
PubMed
Close
,
B Kiec-Wilk Department of Metabolic Diseases, Jagiellonian University Medical College
University Hospital, Krakow, Poland

Search for other papers by B Kiec-Wilk in
Google Scholar
PubMed
Close
,
E Pitera Center for Medical Genomics OMICRON, Jagiellonian University Medical College, Krakow, Poland

Search for other papers by E Pitera in
Google Scholar
PubMed
Close
,
P P Wolkow Center for Medical Genomics OMICRON, Jagiellonian University Medical College, Krakow, Poland

Search for other papers by P P Wolkow in
Google Scholar
PubMed
Close
, and
M T Malecki Department of Metabolic Diseases, Jagiellonian University Medical College
University Hospital, Krakow, Poland

Search for other papers by M T Malecki in
Google Scholar
PubMed
Close

diagnosed form of DFS. The yearly incidence rate reported among patients with diabetes has reached 6.0% ( 2 ). It is associated with a high rate of recurrence, amputation, and mortality ( 3 ). The standard management of the DFU includes glycemic control

Open access
L Bahler Internal Medicine, Academic Medical Center, Amsterdam, The Netherlands

Search for other papers by L Bahler in
Google Scholar
PubMed
Close
,
H J Verberne Nuclear Medicine, Academic Medical Center, Amsterdam, The Netherlands

Search for other papers by H J Verberne in
Google Scholar
PubMed
Close
,
E Brakema Internal Medicine, Academic Medical Center, Amsterdam, The Netherlands

Search for other papers by E Brakema in
Google Scholar
PubMed
Close
,
R Tepaske Intensive Care Medicine, Academic Medical Center, Amsterdam, The Netherlands

Search for other papers by R Tepaske in
Google Scholar
PubMed
Close
,
J Booij Nuclear Medicine, Academic Medical Center, Amsterdam, The Netherlands

Search for other papers by J Booij in
Google Scholar
PubMed
Close
,
J B Hoekstra Internal Medicine, Academic Medical Center, Amsterdam, The Netherlands

Search for other papers by J B Hoekstra in
Google Scholar
PubMed
Close
, and
F Holleman Internal Medicine, Academic Medical Center, Amsterdam, The Netherlands

Search for other papers by F Holleman in
Google Scholar
PubMed
Close

. Effect of bromocriptine-QR on glycemic control in subjects with uncontrolled hyperglycemia on one or two oral anti-diabetes agents . Endocrine Practice 2012 18 931 – 943 . ( doi:10.4158/EP12187.OR ) 7 Meier AH Cincotta AH Lovell WC

Open access
L Ahlkvist
Search for other papers by L Ahlkvist in
Google Scholar
PubMed
Close
,
K Brown Department of Clinical Sciences, GlaxoSmithKline, Biomedical Center, C11, Lund University, SE 22184 Lund, Sweden

Search for other papers by K Brown in
Google Scholar
PubMed
Close
, and
B Ahrén
Search for other papers by B Ahrén in
Google Scholar
PubMed
Close

8 1646 – 1655 . ( doi:10.1210/me.8.12.1646 ). 6 Chu ZL Jones RM He H Carroll C Gutierrez V Lucman A Moloney M Gao H Mondala H Bagnol D . A role for β-cell-expressed G protein-coupled receptor 119 in glycemic control by

Open access
Nese Cinar Department of Endocrinology and Metabolism, Hacettepe University School of Medicine, 06100 Sihhiye, Ankara, Turkey

Search for other papers by Nese Cinar in
Google Scholar
PubMed
Close
and
Alper Gurlek Department of Endocrinology and Metabolism, Hacettepe University School of Medicine, 06100 Sihhiye, Ankara, Turkey

Search for other papers by Alper Gurlek in
Google Scholar
PubMed
Close

-Mesallamy et al . (49) found higher vaspin concentrations in both obese and non-obese type 2 diabetes patients than in controls, whereas diabetic women with good glycemic control had lower vaspin levels than those with poor glycemic control in another study

Open access
Alexis Sudlow Department of Upper GI Surgery, Southmead Hospital, Bristol, UK

Search for other papers by Alexis Sudlow in
Google Scholar
PubMed
Close
,
Carel W le Roux Department of Experimental Pathology, University College Dublin, Dublin, Ireland

Search for other papers by Carel W le Roux in
Google Scholar
PubMed
Close
, and
Dimitri J Pournaras Department of Upper GI Surgery, Southmead Hospital, Bristol, UK

Search for other papers by Dimitri J Pournaras in
Google Scholar
PubMed
Close

-009-0080-9 ) 21 Kalinowski P Paluszkiewicz R Wróblewski T Remiszewski P Grodzicki M Bartoszewicz Z Krawczyk M . Ghrelin, leptin, and glycemic control after sleeve gastrectomy versus Roux-en-Y gastric bypass-results of a randomized clinical trial

Open access